A detailed history of Central Bank & Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Central Bank & Trust CO holds 31,678 shares of NVO stock, worth $3.22 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
31,678
Previous 495 6299.6%
Holding current value
$3.22 Million
Previous $70,000 5287.14%
% of portfolio
0.53%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$119.07 - $145.42 $3.71 Million - $4.53 Million
31,183 Added 6299.6%
31,678 $3.77 Million
Q2 2024

Jul 19, 2024

BUY
$122.71 - $146.91 $60,741 - $72,720
495 New
495 $70,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Central Bank & Trust CO Portfolio

Follow Central Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.